{"id":169,"date":"2021-11-21T01:57:54","date_gmt":"2021-11-21T01:57:54","guid":{"rendered":"https:\/\/quimicaambiental.org\/blog\/2021\/11\/21\/protocolo-de-uso-de-inducao-de-imunotolerancia\/"},"modified":"2021-11-21T01:57:54","modified_gmt":"2021-11-21T01:57:54","slug":"protocolo-de-uso-de-inducao-de-imunotolerancia","status":"publish","type":"post","link":"https:\/\/quimicaambiental.org\/?p=169","title":{"rendered":"Protocolo de Uso de Indu\u00e7\u00e3o de Imunotoler\u00e2ncia"},"content":{"rendered":"<p> [ad_1]<br \/>\n<\/p>\n<p>A Portaria MS n\u00ba 1114 de 16.11.2021 (DOU de 19\/11\/2021 Se\u00e7\u00e3o I P\u00e1g. 201) redefine o Protocolo de Uso de Indu\u00e7\u00e3o de Imunotoler\u00e2ncia para Indiv\u00edduos com Hemofilia A e Inibidor.<\/p>\n<p>Neste instrumento fica redefinido o Protocolo de Uso de Indu\u00e7\u00e3o de Imunotoler\u00e2ncia para Indiv\u00edduos com Hemofilia A e Inibidor dispon\u00edvel no s\u00edtio https:\/\/www.gov.br\/saude\/pt-br\/assuntos\/protocolos-clinicos-e-diretrizes-terapeuticas-pcdt.<\/p>\n<p>O Protocolo citado cont\u00e9m orienta\u00e7\u00f5es relacionadas ao procedimento para indu\u00e7\u00e3o de imunotoler\u00e2ncia em indiv\u00edduos com hemofilia A que tenham desenvolvido inibidor persistente contra o fator VIII da coagula\u00e7\u00e3o, que interfere com a profilaxia e\/ou tratamento sob demanda de eventos hemorr\u00e1gicos com o concentrado de fator VIII e que demandam tratamento com agentes bypassing<\/p>\n<p>&nbsp;<\/p>\n<p>Acesse o link<\/p>\n<p><a href=\"http:\/\/www.in.gov.br\/web\/dou\/-\/portaria-n-1.114-de-16-de-novembro-de-2021-360545310\">http:\/\/www.in.gov.br\/web\/dou\/-\/portaria-n-1.114-de-16-de-novembro-de-2021-360545310<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>O post <a rel=\"nofollow\" href=\"https:\/\/estudoemfocosaude.com.br\/protocolo-de-uso-de-inducao-de-imunotolerancia\/\">Protocolo de Uso de Indu\u00e7\u00e3o de Imunotoler\u00e2ncia<\/a> apareceu primeiro em <a rel=\"nofollow\" href=\"https:\/\/estudoemfocosaude.com.br\">EFS<\/a>.<\/p>\n<p>[ad_2]<br \/>\n<br \/><a href=\"https:\/\/estudoemfocosaude.com.br\/protocolo-de-uso-de-inducao-de-imunotolerancia\/\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>[ad_1] A Portaria MS n\u00ba 1114 de 16.11.2021 (DOU de 19\/11\/2021 Se\u00e7\u00e3o I P\u00e1g. 201) redefine o Protocolo de Uso de Indu\u00e7\u00e3o de Imunotoler\u00e2ncia para Indiv\u00edduos<span class=\"excerpt-hellip\"> [\u2026]<\/span><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[4,6,3,5],"class_list":["post-169","post","type-post","status-publish","format-standard","hentry","tag-higiene","tag-ocupacional","tag-saude","tag-seguranca"],"_links":{"self":[{"href":"https:\/\/quimicaambiental.org\/index.php?rest_route=\/wp\/v2\/posts\/169","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/quimicaambiental.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/quimicaambiental.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/quimicaambiental.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/quimicaambiental.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=169"}],"version-history":[{"count":0,"href":"https:\/\/quimicaambiental.org\/index.php?rest_route=\/wp\/v2\/posts\/169\/revisions"}],"wp:attachment":[{"href":"https:\/\/quimicaambiental.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=169"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/quimicaambiental.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=169"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/quimicaambiental.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=169"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}